Promising
Omega-3
The prediction game
Call it: rising or fading?
Where does Omega-3 stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: B (good evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 6.8/10
Omega-3 is a 6.8 / 10 fit for people using cardiovascular, anti inflammatory, and metabolic health as a measured experiment, not a belief-based staple. The best anchors are [Kaviani et al. 2022](https://www.sciencedirect.com/science/article/abs/pii/S1567576922005884), which reports umbrella meta-analysis and CRP, IL-6, and TNF-alpha reductions support modest anti-inflammatory effect, and [Zhang et al. 2025](https://pmc.ncbi.nlm.nih.gov/articles/PMC12129820/), which reports 23 randomized trials, 2,061 participants and reduced triglycerides and total cholesterol, no significant plaque-volume effect. That gives Omega-3 a real signal, but the report should stay narrow because responder fit, baseline status, and outcome tracking drive the practical value. Use Omega-3 when the target is specific, measurable, and worth the tradeoff. Skip or stop Omega-3 when the expected symptom, lab, or performance marker stays flat. ✅ Best for: People with documented low Omega-3 Index below 5%; patients with elevated triglycerides who are using clinician-directed prescription EPA or high-quality EPA/DHA protocols; adults using EPA-dominant omega-3 as an adjunct for unipolar depression; rheumatoid arthritis patients seeking modest pain and NSAID-sparing support; chronic pain patients where inflammation is part of the picture; pregnant or lactating women using purified DHA or algae oil after clinician review; and vegans using direct EPA/DHA algae oil instead of relying on ALA conversion. ❌ Avoid if: You already eat fatty fish 2-3 times weekly and have a solid Omega-3 Index; you have atrial fibrillation, frequent palpitations, or high cardiovascular-risk status and want high-dose omega-3 without clinician oversight; you use warfarin or dual antiplatelet therapy without monitoring; you have fish allergy and are considering fish oil; you have shellfish allergy and are considering krill oil; or you are tempted by bargain fish oil with no third-party freshness testing. Also skip omega-3 if buying capsules becomes a way to avoid fixing diet quality.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 15.1%
- BioHarmony Score
- 6.8/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.